Qualigen Therapeutics, Inc. (QLGN)
QLGN Stock Price Chart
Explore Qualigen Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze QLGN price movements and trends.
QLGN Company Profile
Discover essential business fundamentals and corporate details for Qualigen Therapeutics, Inc. (QLGN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
23 Jun 2015
Employees
4.00
Website
https://qlgntx.comCEO
Kevin A. Richardson II
Description
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
QLGN Financial Timeline
Browse a chronological timeline of Qualigen Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Nov 2025
Earnings released on 16 Aug 2025
EPS came in at -$1.82 .
Earnings released on 14 Aug 2025
EPS came in at -$1.00 .
Earnings released on 21 Jul 2025
EPS came in at -$1.82 , while revenue for the quarter reached $2.24M .
Earnings released on 14 Nov 2024
EPS came in at -$4.70 , while revenue for the quarter reached $426.92K .
Stock split effective on 5 Nov 2024
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 2 Jul 2024
EPS came in at -$17.50 .
Earnings released on 25 Jun 2024
EPS came in at -$0.47 surpassing the estimated -$26.00 by +98.19%.
Earnings released on 30 Apr 2024
EPS came in at -$0.47 .
Earnings released on 14 Nov 2023
EPS came in at -$32.00 surpassing the estimated -$46.00 by +30.43%, while revenue for the quarter reached $7.94M , beating expectations by +1.49K%.
Earnings released on 15 Aug 2023
EPS came in at -$34.50 falling short of the estimated -$26.00 by -32.69%, while revenue for the quarter reached $1.63M , beating expectations by +17.05%.
Earnings released on 16 May 2023
EPS came in at -$39.00 surpassing the estimated -$42.50 by +8.24%, while revenue for the quarter reached $1.61M , beating expectations by +15.62%.
Earnings released on 30 Mar 2023
EPS came in at -$1.50 falling short of the estimated -$1.40 by -7.14%, while revenue for the quarter reached $1.39M , missing expectations by -11.47%.
Stock split effective on 23 Nov 2022
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 Nov 2022
EPS came in at -$50.00 falling short of the estimated -$1.30 by -3.75K%, while revenue for the quarter reached $1.44M , missing expectations by -11.05%.
Earnings released on 16 Aug 2022
EPS came in at -$55.00 surpassing the estimated -$90.00 by +38.89%, while revenue for the quarter reached $1.43M , beating expectations by +19.21%.
Earnings released on 13 May 2022
EPS came in at -$70.00 falling short of the estimated -$1.70 by -4.02K%, while revenue for the quarter reached $722.03K , missing expectations by -16.09%.
Earnings released on 31 Mar 2022
EPS came in at -$75.00 falling short of the estimated -$2.05 by -3.56K%, while revenue for the quarter reached $1.48M , beating expectations by +11.88%.
Earnings released on 15 Nov 2021
EPS came in at -$50.00 surpassing the estimated -$105.00 by +52.38%, while revenue for the quarter reached $1.16M , missing expectations by -34.00%.
Earnings released on 17 Aug 2021
EPS came in at -$90.00 , while revenue for the quarter reached $1.12M , missing expectations by -34.24%.
Earnings released on 14 May 2021
EPS came in at -$105.00 falling short of the estimated -$1.60 by -6.46K%, while revenue for the quarter reached $1.90M , missing expectations by -15.79%.
Earnings released on 31 Mar 2021
EPS came in at $8.50 surpassing the estimated -$1.30 by +753.85%, while revenue for the quarter reached $1.11M .
Earnings released on 13 Nov 2020
EPS came in at -$95.00 falling short of the estimated -$50.00 by -90.00%, while revenue for the quarter reached $837.71K , missing expectations by -47.09%.
QLGN Stock Performance
Access detailed QLGN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.